Literature DB >> 20865025

Acute coronary syndromes: long-term impact of routine versus invasive ACS management.

Charles V Pollack1, George W Christy.   

Abstract

Entities:  

Mesh:

Year:  2010        PMID: 20865025     DOI: 10.1038/nrcardio.2010.125

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  10 in total

1.  The TIMI risk score for unstable angina/non-ST elevation MI: A method for prognostication and therapeutic decision making.

Authors:  E M Antman; M Cohen; P J Bernink; C H McCabe; T Horacek; G Papuchis; B Mautner; R Corbalan; D Radley; E Braunwald
Journal:  JAMA       Date:  2000-08-16       Impact factor: 56.272

2.  5-year outcome of an interventional strategy in non-ST-elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial.

Authors:  K A A Fox; P Poole-Wilson; T C Clayton; R A Henderson; T R D Shaw; D J Wheatley; R Knight; S J Pocock
Journal:  Lancet       Date:  2005 Sep 10-16       Impact factor: 79.321

3.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban.

Authors:  C P Cannon; W S Weintraub; L A Demopoulos; R Vicari; M J Frey; N Lakkis; F J Neumann; D H Robertson; P T DeLucca; P M DiBattiste; C M Gibson; E Braunwald
Journal:  N Engl J Med       Date:  2001-06-21       Impact factor: 91.245

Review 4.  Long-term outcome of a routine versus selective invasive strategy in patients with non-ST-segment elevation acute coronary syndrome a meta-analysis of individual patient data.

Authors:  Keith A A Fox; Tim C Clayton; Peter Damman; Stuart J Pocock; Robbert J de Winter; Jan G P Tijssen; Bo Lagerqvist; Lars Wallentin
Journal:  J Am Coll Cardiol       Date:  2010-03-30       Impact factor: 24.094

5.  5-year outcomes in the FRISC-II randomised trial of an invasive versus a non-invasive strategy in non-ST-elevation acute coronary syndrome: a follow-up study.

Authors:  Bo Lagerqvist; Steen Husted; Fredrik Kontny; Elisabeth Ståhle; Eva Swahn; Lars Wallentin
Journal:  Lancet       Date:  2006-09-16       Impact factor: 79.321

6.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial. FRISC II Investigators. Fast Revascularisation during Instability in Coronary artery disease.

Authors:  L Wallentin; B Lagerqvist; S Husted; F Kontny; E Ståhle; E Swahn
Journal:  Lancet       Date:  2000-07-01       Impact factor: 79.321

7.  Early invasive versus selectively invasive management for acute coronary syndromes.

Authors:  Robbert J de Winter; Fons Windhausen; Jan Hein Cornel; Peter H J M Dunselman; Charles L Janus; Peter E F Bendermacher; H Rolf Michels; Gerard T Sanders; Jan G P Tijssen; Freek W A Verheugt
Journal:  N Engl J Med       Date:  2005-09-15       Impact factor: 91.245

8.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial. Randomized Intervention Trial of unstable Angina.

Authors:  K A A Fox; P A Poole-Wilson; R A Henderson; T C Clayton; D A Chamberlain; T R D Shaw; D J Wheatley; S J Pocock
Journal:  Lancet       Date:  2002-09-07       Impact factor: 79.321

9.  5-year clinical outcomes in the ICTUS (Invasive versus Conservative Treatment in Unstable coronary Syndromes) trial a randomized comparison of an early invasive versus selective invasive management in patients with non-ST-segment elevation acute coronary syndrome.

Authors:  Peter Damman; Alexander Hirsch; Fons Windhausen; Jan G P Tijssen; Robbert J de Winter
Journal:  J Am Coll Cardiol       Date:  2010-01-04       Impact factor: 24.094

10.  Predictors of hospital mortality in the global registry of acute coronary events.

Authors:  Christopher B Granger; Robert J Goldberg; Omar Dabbous; Karen S Pieper; Kim A Eagle; Christopher P Cannon; Frans Van De Werf; Alvaro Avezum; Shaun G Goodman; Marcus D Flather; Keith A A Fox
Journal:  Arch Intern Med       Date:  2003-10-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.